The Food and Drug Administration announced the availability of draft guidance that provides recommendations on lifecycle controls in submissions to market machine learning-enabled device software functions.
WHY IT MATTERS
In the “Marketing Submission Recommendations for a Predetermined Change…
From: www.healthcareitnews.com – Read more
4 common AI adoption roadblocks and how to avoid them
Generative AI can enhance patient experiences and health outcomes, but trust, accuracy, staff training, and the protection of intellectual property are hurdles to its implementation
